102 related articles for article (PubMed ID: 3874000)
21. Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.
Newman EM; Akman SA; Harrison JS; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Somlo G; Ahn CW; Doroshow JH
Cancer Res; 1992 May; 52(9):2408-12. PubMed ID: 1568210
[TBL] [Abstract][Full Text] [Related]
22. 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update.
Marini G; Simoncini E; Zaniboni A; Gorni F; Marpicati P; Zambruni A
Oncology; 1987; 44(6):336-40. PubMed ID: 3500441
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with 5-fluorouracil (5-FU) and high-dose folinic acid in solid tumors.
Marini G; Zaniboni A; Gorni F; Marpicati P; Montini E; Simoncini E
Drugs Exp Clin Res; 1987; 13(6):373-6. PubMed ID: 3498615
[TBL] [Abstract][Full Text] [Related]
24. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
[TBL] [Abstract][Full Text] [Related]
25. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
26. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H; Bauernhofer T; Schmid M; Ploner F; Moser R; Derstvenscheg E; Steindorfer P; Wilders-Truschnig M; Kuss I; Samonigg H
Cancer Chemother Pharmacol; 1994; 35(2):174-8. PubMed ID: 7987997
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial with 5-fluorouracil and high-dose folinic acid, using new sequential dosing schedule, in pretreated advanced breast cancer patients.
Zola P; Bergamino T; Katsaros D; Ferrero A; Ciancio A; Bellora G; Sismondi P
Eur J Gynaecol Oncol; 1992; 13(6):527-32. PubMed ID: 1473534
[TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
Palmeri S; Gebbia V; Russo A; Gebbia N; Meli M; Rausa L
J Chemother; 1991 Jun; 3(3):176-9. PubMed ID: 1919655
[TBL] [Abstract][Full Text] [Related]
29. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Stöger H; Bauernhofer T; Kasparek AK; Schmid M; Moser R; Ploner F; Derstvenscheg E; Kuss I; Wilders-Truschnig M; Steindorfer P
Cancer Chemother Pharmacol; 1994; 34(1):75-8. PubMed ID: 8174206
[TBL] [Abstract][Full Text] [Related]
30. Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.
Francini G; Petrioli R; Aquino A; Gonnelli S
Cancer Chemother Pharmacol; 1993; 32(5):359-64. PubMed ID: 7687933
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Stöger H; Schmid M; Bauernhofer T; Moser R; Ploner F; Derstvenscheg E; Kasparek AK; Kuss I; Wilders-Truschnig M; Lackner C
Oncology; 1994; 51(6):518-22. PubMed ID: 7970497
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of 5-fluorouracil plus high-dose folinic acid in the treatment of recurrent small cell lung cancer.
Stewart DJ; Dahrouge S; Soltys KM; Evans WK
Am J Clin Oncol; 1995 Apr; 18(2):130-2. PubMed ID: 7900705
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin plus 5-fluorouracil and leucovorin in previously treated patients with metastatic breast cancer.
Fiorentino MV; Brandes A
Ann Oncol; 1992 Aug; 3 Suppl 3():28-32. PubMed ID: 1390314
[TBL] [Abstract][Full Text] [Related]
34. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
Hainsworth JD
Ann Oncol; 1993; 4 Suppl 2():37-40. PubMed ID: 7688982
[TBL] [Abstract][Full Text] [Related]
35. L-folinic acid and 5-fluorouracil in the treatment of advanced breast cancer: a phase II study.
Zaniboni A; Meriggi F; Arcangeli G; Marpicati P; Montini E; Simoncini E; Marini G
Ann Oncol; 1993; 4 Suppl 2():41-3. PubMed ID: 8353103
[TBL] [Abstract][Full Text] [Related]
36. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Becouarn Y; Brunet R; Bussières E; Marée D
Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
[TBL] [Abstract][Full Text] [Related]
37. High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer.
Kamphuis JT; Huider MC; Ras GJ; Verhagen CA; Kateman I; Vreeswijk JH; Burghouts JT
Cancer Chemother Pharmacol; 1995; 37(1-2):190-2. PubMed ID: 7497592
[TBL] [Abstract][Full Text] [Related]
38. The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.
Jolivet J; Bélanger K; Yelle L; Guévin R; Potvin M; Wilson J; Rudinskas L; Latreille J; Dionne J; Gagné L
Eur J Cancer; 1994; 30A(5):626-8. PubMed ID: 8080677
[TBL] [Abstract][Full Text] [Related]
39. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.
Wilke H; Preusser P; Fink U; Achterrath W; Lenaz L; Stahl M; Schober C; Link H; Meyer HJ; Lucke B
Invest New Drugs; 1990 Feb; 8(1):65-70. PubMed ID: 2345071
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer.
Fine S; Erlichman C; Kaizer L; Warr D; Gadalla T
Breast Cancer Res Treat; 1994; 30(2):205-9. PubMed ID: 7949219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
